NCT00197210View on ClinicalTrials.gov

A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants

PHASE3CompletedINTERVENTIONAL

Enrollment

10,708

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL

Rotavirus

Trial Locations (4)

119074

GSK Investigational Site, Singapore

228510

GSK Investigational Site, Singapore

229899

GSK Investigational Site, Singapore

308433

GSK Investigational Site, Singapore

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY